Western Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Western Wealth Management's GILD Position: Q1 2026 in Review
Western Wealth Management increased its Gilead Sciences (GILD) stake by 105% in Q1 2026, buying an estimated $570K and bringing the position to 7,949 shares worth $1.11M. The position accounts for 0.04% of the portfolio, ranked #414.
Western Wealth Management first reported a position in GILD in Q4 2018 and has held it in 23 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Western Wealth Management held 7,949 shares of Gilead Sciences worth $1.11M as of Q1 2026.
- Western Wealth Management bought 4,068 Gilead Sciences shares in Q1 2026, an estimated $570K.
- Gilead Sciences made up 0.04% of Western Wealth Management's portfolio in Q1 2026, its #414 holding.
- Western Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 23 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.